Product
PD-1antibody
1 clinical trial
1 indication
Indication
Perihilar CholangiocarcinomaClinical trial
PD-1 Antibody Plus Gemcitabine and Oxaliplatin (GEMOX) as Postoperative Adjuvant Therapy in Perihilar Cholangiocarcinoma Patients With Positively Metastatic Lymph Nodes : a Single Arm, Phase II TrialStatus: Recruiting, Estimated PCD: 2024-01-31